Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ASCO presentation documents safety of TLK-286 over wide dose range, efficacy in advanced cancer

May 21, 2001

GTI-2040 safe and well tolerated in initial dose-escalating trial

May 21, 2001

Replication-competent virus for i.v. administration tested in cancer patients

May 21, 2001

P&G discovers new hydroxamic acid-based MMP inhibitors

May 18, 2001

Angiogenesis inhibitors from Bayer act on KDR kinase

May 18, 2001

Thalomid/Camptosar combination study for metastatic colorectal cancer begins

May 18, 2001

Telik awarded SBIR grant for cancer drug discovery

May 18, 2001

Response and survival data for RSR-13 in NSCLC discussed at ASCO

May 18, 2001

Repeated doses of chimeric MAb safe and effective in early trial in RCC

May 18, 2001

AGI Dermatics and Elan form alliance for Dimericine

May 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...